This was the stock's eighth consecutive day of gains.
Zimmer Biomet Holdings (NYSE:ZBH) has had a rough month with its share price down 5.4%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look ...
Principal Securities Inc. boosted its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 23.7% in ...
Principal Financial Group Inc. lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 4.0% ...
This collaboration demonstrates Zimmer Biomet’s commitment to expanding access to its advanced technologies and innovation ...
Legal (South Asia) at medical device manufacturer Zimmer Biomet. Malhotra holds an LL.M. from National Law Unive ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immunovant (IMVT – Research Report), Summit Therapeutics ...
Shares of Zimmer Biomet Holdings Inc. ZBH slipped 1.43% to $98.98 Tuesday, on what proved to be an all-around great trading ...
The China Anti-Osteoporosis Fracture Healing industry is on a trajectory of sustained growth, with market valuation expected to reach USD 1,688.3 million by 2025, expanding at a steady annual growth ...
In the third quarter of 2024, Zimmer Biomet reported sales of $1.82 billion, representing an approximate 4% year-over-year growth and aligning with consensus estimates. The company's adjusted ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has announced the issuance of a series of new notes totaling $1.75 billion on Wednesday. The medical device company, currently trading near its 52-week low ...